HPV-infection. Cervical carcinoma is worldwide the third most frequent carcinoma affecting women regionally, it is sometimes even the most frequent form of female cancer. Moreover, anogenital dysplasia and genital warts represent a major health care problem. With the development of bivalent and quadrivalent prophylactic vaccines against HPV 16 and 18 or HPV 6, 11, 16 and 18, respectively, a very promising immunoprophylaxis is now available to prevent the development of HPV-associated diseases and in particular, cervical carcinoma.